Literature DB >> 35821560

Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis.

Zhe Xu Cao1, Xin Weng2, Jiang Sheng Huang1, Xia Long3.   

Abstract

Log odds of positive lymph nodes (LODDS) is an independent prognostic factor for patients with medullary thyroid carcinoma (MTC). However, the optimal cutoff value for LODDS needs to be further confirmed, and previous studies have ignored the prevalent competing events of non-cancer deaths among patients with MTC, thus possibly overestimating the risk of death from cancer. The information of patients with MTC who underwent total thyroidectomy was collected from SEER database. Restricted cubic splines (RCS) were used to determine the optimal cutoff for LODDS. Moreover, patients' overall survival (OS) and disease-specific survival (DSS) were determined using Kaplan-Meier and Cox proportional-hazards model. The competing risk models (CRM) were used to reduce the effect of competing events, and propensity score matching was performed to balance the confounding factors between groups. The cutoff value of LODDS determined by RCS was - 1.004, and a total of 2314 patients with MTC were recruited. In the CRM after PSM, factors such as age over 55 years at diagnosis, being male, treatment with chemotherapy or radiotherapy, unknown tumor size, and LODDS > - 1.004 were significantly associated with poor prognosis of patients both in univariate and multivariate analyses, while the presence of multifocal tumor indicated better prognosis. Patients with MTC who were over 55 years old at diagnosis, were male, received chemotherapy or radiation, had an unclear initial tumor size, and had LODDS > - 1.004 had a worse prognosis than patients with multifocal tumor.
© 2022. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Competing risk models; LODDS; Medullary thyroid carcinoma; Propensity score matching; Restricted cubic splines; SEER

Mesh:

Year:  2022        PMID: 35821560     DOI: 10.1007/s13304-022-01320-7

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  39 in total

1.  Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.

Authors:  Emad Kandil; Marta M Gilson; Haytham H Alabbas; Anthony P Tufaro; Alan Dackiw; Ralph P Tufano
Journal:  Ann Surg Oncol       Date:  2010-10-29       Impact factor: 5.344

2.  Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma.

Authors:  T Okusa; Y Nakane; T Boku; H Takada; M Yamamura; K Hioki; M Yamamoto
Journal:  Surg Gynecol Obstet       Date:  1990-06

Review 3.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

4.  PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.

Authors:  Suhael Momin; Deborah Chute; Brian Burkey; Joseph Scharpf
Journal:  Endocr Pract       Date:  2017-07-06       Impact factor: 3.443

5.  Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.

Authors:  Jiajia Tang; Shitao Jiang; Luying Gao; Xuehua Xi; Ruina Zhao; Xingjian Lai; Bo Zhang; Yuxin Jiang
Journal:  Ann Surg Oncol       Date:  2021-01-19       Impact factor: 5.344

6.  Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.

Authors:  Nienke A de Glas; Mandy Kiderlen; Jan P Vandenbroucke; Anton J M de Craen; Johanneke E A Portielje; Cornelis J H van de Velde; Gerrit-Jan Liefers; Esther Bastiaannet; Saskia Le Cessie
Journal:  J Natl Cancer Inst       Date:  2015-11-26       Impact factor: 13.506

7.  The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer.

Authors:  Jiping Wang; James M Hassett; Merril T Dayton; Mahmoud N Kulaylat
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

8.  Medullary thyroid carcinoma: a 30-year experience at one institution in Korea.

Authors:  Cho Rok Lee; Sohee Lee; Haiyoung Son; Eunjeong Ban; Sang-Wook Kang; Jandee Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Ann Surg Treat Res       Date:  2016-11-25       Impact factor: 1.859

Review 9.  A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma.

Authors:  Masoumeh Mohammadi; Mehdi Hedayati
Journal:  Cell J       Date:  2016-09-26       Impact factor: 2.479

10.  Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.

Authors:  Mohamed Abdelgadir Adam; Samantha Thomas; Sanziana A Roman; Terry Hyslop; Julie A Sosa
Journal:  JAMA Surg       Date:  2017-09-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.